Scott Henry, DPM
Podiatrist · Frederick, MDNPI 1255324539
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,025 of the $1,649 with a category attached, or 62.1%. Treace Medical Concepts, Inc. accounts for 68.7% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2021 at $1,190 and has fallen 93.0% since, to $83 in 2025.
Across 22 payments — averaging $74.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$1K
- Bioventus LLC$96
- Axogen$91
- Encore Medical, LP$62
- Tactile Systems Technology Inc$60
- Keswick Pharmaceuticals LLC$54
- plus $154 from 9 others
What the payments were for
- Travel & lodging$1,02562%
- Food & beverage$62438%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 3 | $1,133 |
| Bioventus LLC | 2 | $96 |
| Axogen | 1 | $91 |
| Encore Medical, LP | 2 | $62 |
| Tactile Systems Technology Inc | 3 | $60 |
| Keswick Pharmaceuticals LLC | 1 | $54 |
| Melinta Therapeutics, LLC | 2 | $41 |
| Integra Lifesciences Corporation | 1 | $19 |
| Medela LLC | 1 | $16 |
| Stryker | 1 | $14 |
| Merck | 1 | $14 |
| Baudax Bio Inc. | 1 | $13 |
| DJO, LLC | 1 | $13 |
| Smith+Nephew | 1 | $12 |
| Osteomed LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$1,099
How this compares
$1,649 in reported general payments places this provider in the 65th percentile of 183 podiatrist providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 131 | $4,329 |
| Gabapentin | 191 | $2,832 |
| Colchicine | 11 | $226 |
| Cephalexin | 16 | $158 |
| Meloxicam | 29 | $72 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Frederick
- Shashank SrivastavaFrederick$15K
- Sana ShamimFrederick$2K
- Ijeoma NwujuBethesda$601K
- David Linla Plata$75K
- Ira GottliebPasadena$25K
- Teresa HilliardHyattsville$19K
- Andreas KaikisHagerstown$17K
- Tiffany HohBaltimore$17K
- Hayden HofflerCatonsville$15K
- Enzo LeonePasadena$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.